BG Medicine, Mitsubishi Pharma Partner on Biomarker Discovery for Muscle Toxicity | GenomeWeb

NEW YORK, March 28 (GenomeWeb News) - BG Medicine said today that it has signed a collaborative research agreement with Mitsubishi Pharma of Osaka, Japan, to discover biomarkers associated with muscle toxicity in lipid-lowering compounds.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.